Table 3 Treatment related morbidity is a significant clinical problem in patients with DTC
From: Treatment related morbidity in differentiated thyroid cancer–a survey of clinicians
Profession | NA | Strongly disagree | Disagree | Neutral | Agree | Strongly agree |
|---|---|---|---|---|---|---|
Surgeons | 0 (0.0%) | 4 (5.0%) | 40 (50.0%) | 15 (18.8%) | 17 (21.2%) | 4 (5.0%) |
Physicians | 0 (0.0%) | 0 (0.0%) | 12 (31.6% | 10 (26.3%) | 14 (36.8%) | 2 (5.3%) |